James Phillips

Directeur Général chez Paion Deutschland GmbH

Profil

James Neil Phillips is the founder of Talisker Pharma Ltd. which was founded in 2004.
He held the position of Chief Executive Officer from 2004 to 2006.
Currently, he holds the position of Non-Executive Director at Insense Ltd. since 2011, Co-Managing Director at Paion Deutschland GmbH, and Non-Executive Director at Aplagon Oy.
He was also the Chief Executive Officer & Executive Director at Biodexa Pharmaceuticals Plc from 2013 to 2018.
Additionally, he held several other positions such as Non-Executive Chairman at Prosonix Ltd. from 2007 to 2012, Director at CRF Box Oy, Director at Healthcare Brands International Ltd. from 2011 to 2013, Director at West Sussex Health Authority, Director at Lifegard Technologies, Director at Diabetology Ltd., Director at EUSA Pharma SAS, and Independent Director at Herantis Pharma Oyj.
Dr. Phillips also worked as a Senior Executive at Johnson & Johnson, Novartis AG, and Jazz Pharmaceuticals UK Ltd. He was the President at Eusa Pharma Europe Ltd. from 2006 to 2007 and Senior Vice President-Corporate Development at EUSA Pharma, Inc. Dr. Phillips holds an MBA degree from Bayes Business School.

Postes actifs de James Phillips

Sociétés	Poste	Début
Aplagon Oy	Directeur/Membre du Conseil	-
Paion Deutschland GmbH	Directeur Général	-

Anciens postes connus de James Phillips

Sociétés	Poste	Fin
PAION AG	Directeur Général	30/11/2022
ImevaX GmbH	Directeur Général	01/10/2019
BIODEXA PHARMACEUTICALS PLC	Directeur Général	31/05/2018
Healthcare Brands International Ltd.	Directeur/Membre du Conseil	01/04/2013
Jazz Pharmaceuticals UK Ltd.	President	-